Advertisement.

LYRA Projected Dividend Yield

Lyra Therapeutics Inc ( NASDAQ : LYRA )

Lyra Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of therapies for the treatment of patients with chronic rhinosinusitis (CRS). Co.'s technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. Co.'s product candidates, LYR-210, which is designed to treat CRS patients both with and without nasal polyps who have failed previous medical management and have not undergone endoscopic sinus surgery; and LYR-220, which is also designed to utilize mometasone furoate, and employs a larger matrix designed for patients whose nasal cavity is enlarged due to sinus surgery.

20 YEAR PERFORMANCE RESULTS

LYRA Dividend History Detail
LYRA Dividend News
LYRA Competitors News

# of Shares: 0

Closing Price: 0.38

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000